News Article
Material agreement
IBM decides on HFIP supplier
Halocarbon Products Corporation has entered into a licensing agreement with IBM to access IBM’s industry-leading portfolio of patents related to hexafluoroisopropanol-based photoresists for semiconductor manufacturing.
"Halocarbon has long produced hexafluoroisopropanol (HFIP) as a key component in the manufacture of the anesthetic sevoflurane," said Halocarbon CEO Peter Murin.
"With this agreement , we can partner our fluorochemicals development and manufacturing expertise with IBM’s leadership in developing advanced electronic materials such as photoresists."
"This agreement will allow us to leverage our HFIP business and provide reliable, regular, cost–effective, US-based production of advanced photoresist compounds," added Murin.
